$USNA News

USANA Health Sciences, Inc. (USNA) Q1 2026 Earnings Call Transcript

Usana Health Sciences Q1 2026 Earnings Call Transcript

USANA Health Sciences (NYSE:USNA) Q1 Earnings Beat Triggers After-Hours Rally

USANA's CellSentials Supplement Earns Independent Quality Seal

RARE's DTX301 Meets First Key Goal in Phase III OTC Deficiency Study

2 Profitable Stocks Worth Your Attention and 1 We Brush Off

RLMD Stock Surges 42% in a Week: Here's What You Should Know

USANA Health (USNA) Loses 16.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Roche's Giredestrant Misses Key Goal in First-Line Breast Cancer Study

QURE Stock Crashes 32% in a Week: Here's What You Should Know

USANA Health (USNA) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

CANF Stock Soars 20% on Positive Mid-Stage Pancreatic Cancer Data

ACAD Plans Re-Examination After CHMP Rejects Rett Syndrome Drug in EU (Revised)

USANA Looks Like An Undervalued Turnaround Stock

ACAD Plans Re-Examination After CHMP Rejects Rett Syndrome Drug in EU

190 USANA-Sponsored Athletes Earn a Record 28 Medals at 2026 Winter Olympic Games

USANA Health Sciences to Participate in Upcoming Investor Conferences

USANA Health Sciences, Inc. (USNA) Q4 2025 Earnings Call Transcript

USANA Health Sciences shares are trading higher after the company reported better-than-expected Q4 financial results and issued FY26 adjusted EPS guidance above estimates.

USANA Health Sciences Inc (NYSE:USNA) Reports Mixed Q4 Results with Strong EPS Beat and Positive 2026 Outlook